Evidence map›Paper›PMID 23908053›Full record

ArticleThe Laryngoscope2014

RGS21, a regulator of taste and mucociliary clearance?

Adam J Kimple, Alaina L Garland, Staci P Cohen, Vincent Setola, Francis S Willard, Thomas Zielinski, Robert G Lowery, Robert Tarran, David P Siderovski

Abstract read
In one paragraph

Article in The Laryngoscope, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Adam J KimpleDepartment of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, North Carolina, U.S.A; Department of Pharmacology, University of North Carolina at Chapel Hill, North Carolina, U.S.A.
Alaina L Garland
Staci P Cohen
Vincent Setola
Francis S Willard
Thomas Zielinski
Robert G Lowery
Robert Tarran
David P Siderovski
University of North Carolina at Chapel Hill · USBellbrook Labs (United States) · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
SPLUNC1-Derived Peptides as ENaC AntagonistsR01HL108927 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TARRAN, ROBERT · 2012 to 2015
$1.4M
HTS Assays for Modulators of GPCR SignalingR44NS059082 · NINDS · BELLBROOK LABS, LLC · PI LOWERY, ROBERT G · 2009 to 2010
$1.4M
Structural Determinants of Heterotrimeric G-protein Nucleotide CyclingR01GM082892 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SIDEROVSKI, DAVID P. · 2008 to 2011
$924k
Towards small molecule modulators of RGS proteinsF30MH074266 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIMPLE, ADAM J · 2006 to 2011
$162k
The Role of RGS Proteins in the Regulation of Taste TransductionF32DC011670 · NIDCD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COHEN, STACI P · 2011 to 2013
$118k
NHLBI NIH HHS R01 HL108927NIDCD NIH HHS F32 DC011670NIGMS NIH HHS R01 GM082892NIGMS NIH HHS T32 GM008719NIMH NIH HHS F30 MH074266NINDS NIH HHS R44 NS059082
6 · The paper itself

Abstract

objectives/hypothesisMotile cilia of airway epithelial cells help to expel harmful inhaled material. Activation of bitterant-responsive G protein-coupled receptors (GPCRs) is believed to potentiate cilia beat frequency and mucociliary clearance. In this study, we investigated whether regulator of G protein signaling-21 (RGS21) has the potential to modulate signaling pathways connected to airway mucociliary clearance, given that RGS proteins modulate GPCR signaling by acting as GTPase-accelerating proteins (GAPs) for the Gα subunits of heterotrimeric G proteins. STUDY

designThis is a pilot investigation to determine if RGS21, a potential tastant specific RGS gene, is expressed in sinonasal mucosa, and to determine its specific Gα substrate using in vitro biochemical assays with purified proteins.

methodsRgs21 expression in sinonasal mucosa was determined using quantitative, real-time PCR and a transgenic mouse expressing RFP from the Rgs21 promoter. Rgs21 was cloned, over-expressed, and purified using multistep protein chromatography. Biochemical and biophysical assays were used to determine if RGS21 could bind and accelerate the hydrolysis of GTP on heterotrimeric Gα subunits.

resultsRgs21 was expressed in sinonasal mucosa and lingual epithelium. Purified recombinant protein directly bound and accelerated GTP hydrolysis on Gα subunits.

conclusionsRgs21 is expressed in sinonasal mucosa, is amenable to purification as a recombinant protein, and can bind to Gα(i/o/q) subunits. Furthermore, RGS21 can accelerate the hydrolysis rate of GTP on Gαi subunits. This provides evidence that RGS21 may be a negative regulator of bitterant responses. Future studies will be needed to determine the physiological role of this protein in mucociliary clearance.

Indexed as

Gene Expression RegulationAnimalsMiceMice, TransgenicModels, AnimalMucociliary ClearancePilot ProjectsRandom AllocationReal-Time Polymerase Chain ReactionRGS ProteinsSensitivity and SpecificitySignal TransductionTasteRGS ProteinsG proteinsgustationRegulators of G protein signaling (RGS)

Identifiers

PMID23908053
PMCPMC3985343
OpenAlexW2154054669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.